Cargando…
VCE-004.8, A Multitarget Cannabinoquinone, Attenuates Adipogenesis and Prevents Diet-Induced Obesity
Over the past few years, the endocannabinoid system (ECs) has emerged as a crucial player for the regulation of food intake and energy metabolism, and its pharmacological manipulation represents a novel strategy for the management of metabolic diseases. The discovery that VCE-004.8, a dual PPARγ and...
Autores principales: | Palomares, Belen, Ruiz-Pino, Francisco, Navarrete, Carmen, Velasco, Inmaculada, Sánchez-Garrido, Miguel A., Jimenez-Jimenez, Carla, Pavicic, Carolina, Vazquez, Maria J., Appendino, Giovanni, Bellido, M. Luz, Calzado, Marco A., Tena-Sempere, Manuel, Muñoz, Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208444/ https://www.ncbi.nlm.nih.gov/pubmed/30382123 http://dx.doi.org/10.1038/s41598-018-34259-0 |
Ejemplares similares
-
Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy
por: Navarrete, Carmen, et al.
Publicado: (2018) -
The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways
por: del Río, Carmen, et al.
Publicado: (2016) -
Neuroprotection with the Cannabidiol Quinone Derivative VCE-004.8 (EHP-101) against 6-Hydroxydopamine in Cell and Murine Models of Parkinson’s Disease
por: Burgaz, Sonia, et al.
Publicado: (2021) -
Cannabinoquinones: Synthesis and Biological Profile
por: Caprioglio, Diego, et al.
Publicado: (2021) -
VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease
por: Díaz-Alonso, Javier, et al.
Publicado: (2016)